Diabetes Self-Management Blog

The oral diabetes drug metformin may slow the aging process by mimicking the effects of a calorie-restricted diet, according to a new animal study from the United Kingdom. Metformin is believed to be the most commonly prescribed diabetes medicine in the world, with over 48 million prescriptions written in 2010 in the United States alone.

Calorie restriction has been shown, in some cases, to improve health and lengthen life in animals ranging from worms to rhesus monkeys. Similar effects have been noted with the use of metformin, but it has not been clear how the drug might help delay the aging process.

To determine how metformin slows aging, researchers looked at the effects of the medicine on C. elegans worms that were exposed to and colonized by E. coli bacteria — the relationship between these two organisms is similar to that which humans have with healthful bacteria in their gut. (Studies have found that “good” gut bacteria help their host digest and extract nutrients from food, and defects in these bacteria have been linked to metabolic conditions such as Type 2 diabetes and obesity.)

The results showed that the worms lived longer only when the E. coli strain they had been cultured with was sensitive to metformin. In these cases, the worms lived an average of six days longer than usual, equivalent to a third of their normal lifespan.

The researchers discovered that metformin slowed the aging process by altering the metabolism of the E. coli bacteria — specifically, by disrupting the bacteria’s ability to metabolize folate, a type of B vitamin, and methionine, a building block of protein — thereby limiting the nutrients available to the worm, mimicking the effects of a calorie-restricted diet.

When the team added excess sugar to the worms’ diets, however, the life-extending benefits of metformin were cancelled out, a finding that could be particularly relevant for determining how the medicine works in humans.

“We don’t know from this study whether metformin has any effect on human aging. The more interesting finding is the suggestion that drugs that alter bacteria in the gut could give us a new way of treating or preventing metabolic diseases like obesity and diabetes,” noted David Gems, PhD, who directed the research.

In a related study, this one conducted at the University of Montreal, investigators found that metformin may slow the aging process and cancer progression by reducing the production of inflammatory cytokines, a component of the immune system that helps fight infection. (When cytokines are overproduced, it leads to chronic inflammation that is involved in both the aging and cancer processes.) Specifically, metformin disrupted a protein that would typically trigger activation of the immune system.

To learn more about the research looking at metformin and C. elegans, read the article “How Diabetes Drug Delays Aging in Worms” or see the study’s abstract in the journal Cell. And to learn more about metformin, click here.

POST A COMMENT       
  

We are currently experiencing technical difficulties with our commenting system. Thank you for your patience as we work to resolve them.


Oral Medicines
Neuropathy Medicine Recalled; Animas Vibe System Approved (12/05/14)
New Metformin Combination Medicine Approved for Type 2 Diabetes (10/30/14)
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)

Diabetes Research
Sweet-Smelling Breath Holds Promise as Tool for Diagnosing Diabetes (12/22/14)
Painkiller Linked to Low Blood Sugar (12/11/14)
Battling Food Cravings? Try These Strategies. (11/21/14)
A Diabetes Cure in Mice (11/13/14)

Diabetes News
Sweet-Smelling Breath Holds Promise as Tool for Diagnosing Diabetes (12/22/14)
Painkiller Linked to Low Blood Sugar (12/11/14)
Neuropathy Medicine Recalled; Animas Vibe System Approved (12/05/14)
Battling Food Cravings? Try These Strategies. (11/21/14)

Diane Fennell
Sweet-Smelling Breath Holds Promise as Tool for Diagnosing Diabetes (12/22/14)
Painkiller Linked to Low Blood Sugar (12/11/14)
Neuropathy Medicine Recalled; Animas Vibe System Approved (12/05/14)
Battling Food Cravings? Try These Strategies. (11/21/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.